Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity (BLOCK-ROP)

NCT01232777 is registered in ClinicalTrials.gov with Vision Research Foundation as lead sponsor.

NCT NCT01232777
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01232777 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity (BLOCK-ROP)
Lead sponsor
Vision Research Foundation
Phase
Phase 2
Overall status
Withdrawn
Start date
June 30, 2012
Completion date
July 31, 2018
Enrollment
0 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

retinopathy of prematurity